CAT No: CP27071
CAS No:3849-21-6
Synonyms/Alias:3849-21-6;Ethylcyanoglyoxylate-2-oxime;Ethylcyano(hydroxyimino)acetate;Ethyl2-cyano-2-(hydroxyimino)acetate;Ethylisonitrosocyanoacetate;Ethylcyanoglyoxalate-2-oxime;SBB007937;Ethyl(hydroxyimino)cyanoacetate;Ethyloximinocyanoacetate;Aceticacid,cyano(hydroxyimino)-,ethylester;Oxyma;LCFXLZAXGXOXAP-QPJJXVBHSA-N;ethyl(2E)-cyano(hydroxyimino)acetate;Ethyl(2E)-cyano(hydroxyimino)ethanoate;(E)-ethyl2-cyano-2-(hydroxyimino)acetate;ethyl-cyanoacetate;PubChem21633;2-Ethyloximinocyanocaetate;Ethylcyanoglyoxylateoxime;AC1O46QV;Ethylcyanoglyoxalate2-oxime;Ethylcyano(isonitroso)acetate;233412_ALDRICH;ethylcyano(hydroxyimino)formate;MolPort-000-679-504
1. The spatiotemporal control of signalling and trafficking of the GLP-1R
3. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.